#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary fibrosis Adrenogenital syndrome Biotinidase deficiency Progressive supranuclear palsy Waldenstrom's macroglobulinaemia Malignant central nervous system neoplasm Fallopian tube cancer Pyoderma gangrenosum Ehlers-Danlos syndrome Inflammatory myofibroblastic tumour Colon cancer Acute respiratory distress syndrome Non-Hodgkin's lymphoma refractory Chronic graft versus host disease Congenital hypotransferrinaemia More trials…

    Learn about Rare Diseases

    Hypereosinophilic syndrome – Diagnostics Krabbe’s disease – Diagnostics Lymphangiosarcoma – Trials in Disease Mast cell activation syndrome Nodal marginal zone B-cell lymphoma – Basic Information Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Alagille syndrome – Trials in Disease Choroid melanoma – Trials in Disease Mucopolysaccharidosis III – Treatment Isodicentric chromosome 15 syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sertindole Dorzolamide Hydrochloride Meropenem Trihydrate Quinine Dihydrochloride Clonidine Hydrochloride Pancreas Powder Betamethasone Acetate Clozapine Mecillinam Tomligisiran Roflumilast Ranitidine Hydrochloride Treg02 Delafloxacin Dazostinag Trometamol Ucp2 Enlicitide Chloride Argon Methyl Aminolevulinate More therapies…

    Learn about Your Condition

    Hypoalbuminaemia Arteriovenous graft thrombosis Fallopian tube cancer stage IV Craniopharyngioma Intellectual disability Lung cancer metastatic Thyroid mass Hyperglycaemia Heart transplant Strongyloidiasis Paraesthesia Genitourinary tract neoplasm Testicular germ cell cancer Pyelonephritis Constipation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac amyloidosis

  • Study on the Safety of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy Who Completed a Previous Trial

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Acoramidis Hydrochloride
    Belgium Czechia Denmark Greece Ireland Italy +3

  • Study on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

    Not recruiting

    3 1
    Investigated Drugs:
    • Eplontersen
    Austria Belgium Czechia Denmark France Germany +6

  • Study on the Effects of Tafamidis in Patients with Transthyretin Cardiac Amyloidosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Tafamidis
    Portugal

  • Study of Vutrisiran for Patients with Transthyretin Amyloidosis and Heart Disease

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Vutrisiran
    Austria Belgium Croatia Czechia Denmark France +10

  • Study on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

    Not recruiting

    3 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Alxn2220
    Austria Belgium Czechia Denmark France Germany +8

  • Study on the Effectiveness and Safety of CAEL-101 with Drug Combination for Patients with Advanced AL Amyloidosis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Anselamimab
    • Sodium Hydrogen Carbonate Pheur
    • Sodium Chloride Ph. Eur.
    Austria Belgium Czechia France Germany Greece +3
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!